Independent Sector Cancer Network (ISCN) Publish NEW Cancer Service Guidelines

The Independent Sector Cancer Network (ISCN) is a strategic quality governance and safety group which aims to improve independard sector cancer provision though effective collaboration and sharing of best practice across the Independent Sector Cancer Services within the UK.

The ISCN is comprised of expert members who are senior leaders in cancer care, representing nursing, therapeutic radiology, and pharmacy. Over the past years, our team has diligently worked on developing these guidelines to be implemented across the independent sector, aiming to standardise and elevate clinical practice. Although led by the ISCN, this document has transferability to all cancer services.

The ISCN Cancer Service Guidelines 2024 are now readily available for use. These guidelines are designed to:

  • Guide quality of care in practice: Providing a comprehensive framework to ensure the highest standards of patient care.
  • Offer a benchmarking framework: Enabling teams to measure and compare their practices against established standards.
  • Standardize clinical practice: Ensuring consistency and excellence in cancer care across the independent sector.

The ISCN believes these guidelines will significantly contribute to improving patient outcomes and fostering a culture of continuous improvement in cancer care. The ISCN would encourage all teams to integrate these guidelines into their daily practice and use them as a tool for achieving excellence in patient care.

To access the guidelines please click here: https://www.bopa.org.uk/resources/iscn-cancer-service-guidelines/

Please note you need to be a free or paid member of BOPA to access.

Thank you for your commitment to advancing cancer care.

Best regards,
Independent Sector Cancer Network (ISCN)

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article